Chemical / Biological Interfaces

• Charles M. Deber (Hospital for Sick Children / University of Toronto), Discussion Leader
• Peter G. Schultz (University of California, Berkeley), "Lessons from the immune system: From catalysis to material science"
• Steven K. Burley (Rockefeller University), "Structure / function studies of the obesity hormone leptin"

Novel Synthetic Approaches

• James P. Tam (Vanderbilt University), Discussion Leader
• Daniel H. Rich (University of Wisconsin), "Peptidomimetics derived from natural products: Synthesis and properties"
• Barbara Imperiali (California Institute of Technology), "Causes and consequences of asparagine-linked glycosylation"
• K. Barry Sharpless (Science Research Institute), "Asymmetric synthesis of amino acids"
• Murray Goodman (University of California, San Diego), "Enantioselective peptidomimetics: Lanthionine building blocks in drug design"

Receptor-Ligand Interactions

• Tomi K. Sawyer (Parke-Davis / Warner-Lambert), Discussion Leader
• Terry Reisine (University of Pennsylvania), "Structure / function analysis of peptide receptors"
• Todd Somers (Genentech, Inc), "Minimal bioactive conformation of peptidic growth hormone secretagogues"
• Peter W. Schiller (Clinical Research Institute of Montreal), "Opioid peptides and peptidomimetics as pharmacological tools and potential drugs"

Combinatorial Drug Discovery

• Arthur M. Felix (William Paterson College, Wayne, NJ, Discussion Leader
• Jack Baldwin (Pharmacopeia, Inc), "From solid phase peptide synthesis to small molecule combinatorial libraries"
• Eric M. Gordon (Affymax), "Combinatorial organic synthesis: Applications to drug discovery"
• Roger Tung (Vertex Pharmaceuticals), "Confluence of combinatorial and rational drug design"
• Richard A. Houghten (Houghten Pharmaceuticals), "The 'Libraries from Libraries' concept for generation of soluble peptidomimetic and organic combinatorial libraries"

Peptide Templates

• Kenneth D. Kopple (SmithKline Beecham Pharmaceuticals), Discussion Leader
• Arno F. Spanola (University of Louisville), "Chemistry and biology of cylic peptides"
• Victor J. Hruby (University of Arizona), "Exploring topographical space in de novo design: Prospects and problems"
• M. Reza Ghadiri (Scripps Research Institute), "Peptide nanotubes"

Peptide Design

• Teresa M. Kubiak (The Upjohn Company), Discussion Leader
• Andrew Hamilton (University of Pittsburgh), "Design, synthesis & evaluation of peptidomimetic inhibitors of ras farnesyltransferese: A new class of anti-tumor agents"
• Jean Chmielewski (Purdue University), "Dissociation of dimetric proteins: A novel means of enzyme inhibition"
• Daniel F. Veber (SmithKline Beecham Pharmaceuticals), "Studies of solid phase methodology for peptidomimetic libraries"
• James A. Wells (Genentech, Inc.), "Shrinking proteins to peptides"

Peptides in Immunobiology and Inflammation

• John A. Smith (University of Alabama at Birmingham), Discussion Leader
• Mark M. Davis (Stanford University), "Biologcal and chemical aspects of T-cell recognition"
• Hidde L. Ploegh (Massachusetts Institute of Technology), "Creative use of peptides in immunology"
• Douglas K. Miller (Merck Research Laboratories), "Role of ICE family of cysteine proteases in IL-1 activation and apoptosis"

Peptides as Structural Models

• Miklos Bodanszky (Case Western Reserve University), Discussion Leader
• Neville Kallenbach (New York University), "Peptide models for dissecting alpha-helical stability"
• Clare Woodward (University of Minnesota), "NMR characterizatuion of folding intermediates made by peptide synthesis"
• Peter T. Lansbury, Jr. (Massachusetts Institute of Technology), "Amyloid formation in Alzheimer's disease and scrapie"
• Timothy A. Keiderling (University of Illinois at Chicago), "Conformational studies of peptides using optical spectroscopy"